Chi Li
General Counsel bei EDITAS MEDICINE, INC.
Profil
Chi Li is currently the Chief Regulatory Officer & Senior Vice President at Editas Medicine, Inc. Prior to this, he worked as the Chief Regulatory Officer at Celularity, Inc. Dr. Li holds a doctorate degree from Purdue University and an MBA from Rutgers University, Camden.
Aktive Positionen von Chi Li
| Unternehmen | Position | Beginn |
|---|---|---|
| EDITAS MEDICINE, INC. | General Counsel | 14.06.2021 |
Ehemalige bekannte Positionen von Chi Li
| Unternehmen | Position | Ende |
|---|---|---|
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | General Counsel | - |
Ausbildung von Chi Li
| Purdue University | Doctorate Degree |
| Rutgers University, Camden | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EDITAS MEDICINE, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Celularity, Inc. (United States)
Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Commercial Services |
